
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Showing 6 citing articles:
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Nicola Lott, Caroline E. Gebhard, Susan Bengs, et al.
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 217-231
Open Access | Times Cited: 27
Nicola Lott, Caroline E. Gebhard, Susan Bengs, et al.
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 217-231
Open Access | Times Cited: 27
Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
Flavio Cadegiani, Ricardo Ariel Zimerman, Daniel Fonseca, et al.
Cureus (2021)
Open Access | Times Cited: 25
Flavio Cadegiani, Ricardo Ariel Zimerman, Daniel Fonseca, et al.
Cureus (2021)
Open Access | Times Cited: 25
“MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
Pierre Kory, G. Umberto Meduri, José Iglesias, et al.
Journal of Clinical Medicine Research (2022) Vol. 14, Iss. 2, pp. 53-79
Open Access | Times Cited: 5
Pierre Kory, G. Umberto Meduri, José Iglesias, et al.
Journal of Clinical Medicine Research (2022) Vol. 14, Iss. 2, pp. 53-79
Open Access | Times Cited: 5
Androgens’ Role in Severity and Mortality Rates of COVID-19
Ali Ataei, Mohammad Moein Derakhshan, Mohadese Razmjooie, et al.
Hormone and Metabolic Research (2022) Vol. 54, Iss. 12, pp. 813-826
Open Access | Times Cited: 5
Ali Ataei, Mohammad Moein Derakhshan, Mohadese Razmjooie, et al.
Hormone and Metabolic Research (2022) Vol. 54, Iss. 12, pp. 813-826
Open Access | Times Cited: 5
Inhibitory effects of GT0918 on acute lung injury and the molecular mechanisms of anti-inflammatory response
Xiaodan Hou, Honghua Yan, Ao Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Xiaodan Hou, Honghua Yan, Ao Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
Dawei Yang, Min‐Jie Ju, Hao Wang, et al.
BMC Pharmacology and Toxicology (2023) Vol. 24, Iss. 1
Open Access
Dawei Yang, Min‐Jie Ju, Hao Wang, et al.
BMC Pharmacology and Toxicology (2023) Vol. 24, Iss. 1
Open Access